Apogee Therapeutics, Inc. - Common Stock (NQ:APGE)
Price and Volume
Detailed Quote| Volume | 484 |
| Open | 85.37 |
| Bid (Size) | 34.15 (200) |
| Ask (Size) | 136.59 (200) |
| Prev. Close | 85.37 |
| Today's Range | 85.37 - 85.37 |
| 52wk Range | 34.34 - 95.30 |
| Shares Outstanding | 56,367,802 |
| Dividend Yield | N/A |
Top News
More News
Performance
More News
Read More
Gapping stocks in Monday's session ↗
March 23, 2026
Wondering what's happening in today's pre-market session? ↗
March 23, 2026
VR Adviser Adds Over 1 Million Savara Shares ↗
March 15, 2026
Apogee Therapeutics Stock Up 100% as Fund Lifts Stake to $28 Million ↗
February 25, 2026
Apogee Therapeutics to Participate in Upcoming March Conferences
February 24, 2026
Frequently Asked Questions
Is Apogee Therapeutics, Inc. - Common Stock publicly traded?
Yes, Apogee Therapeutics, Inc. - Common Stock is publicly traded.
What exchange does Apogee Therapeutics, Inc. - Common Stock trade on?
Apogee Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Apogee Therapeutics, Inc. - Common Stock?
The ticker symbol for Apogee Therapeutics, Inc. - Common Stock is APGE on the Nasdaq Stock Market
What is the current price of Apogee Therapeutics, Inc. - Common Stock?
The current price of Apogee Therapeutics, Inc. - Common Stock is 85.37
When was Apogee Therapeutics, Inc. - Common Stock last traded?
The last trade of Apogee Therapeutics, Inc. - Common Stock was at 04/28/26 04:00 PM ET
What is the market capitalization of Apogee Therapeutics, Inc. - Common Stock?
The market capitalization of Apogee Therapeutics, Inc. - Common Stock is 4.81B
How many shares of Apogee Therapeutics, Inc. - Common Stock are outstanding?
Apogee Therapeutics, Inc. - Common Stock has 5B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.